Ectopic HMGA2 expression may reverse the antitumor effects of miR‐9, suggesting that the miR‐9/MHGA2 signaling pathway may present a promising therapeutic target for patients with HCC. Here, HMGA2 is linked to hepatocellular carcinoma.